On Thursday, Alcon got a positive adjustment to its Relative Strength (RS) Rating, from 69 to 84.
IBD's unique RS Rating measures technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Decades of market research shows that the best stocks typically have an RS Rating of at least 80 as they launch their biggest price moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
Alcon is working on a consolidation with a 101.10 buy point. See if it can clear the breakout price in volume at least 40% higher than normal.
Earnings growth decreased last quarter from 23% to 3%, but revenue rose from 5% to 6%.
The company earns the No. 15 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
